Acid‐inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects ‐ a randomised open‐label cross‐over study

Summary Background Proton pump inhibitors (PPIs) are widely used for the treatment of acid‐related diseases. Vonoprazan is a member of a new class of acid suppressants; potassium‐competitive acid blockers. Vonoprazan may thus be an alternative to PPIs. Aim To evaluate efficacy, rapidity and duration...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Alimentary pharmacology & therapeutics Ročník 42; číslo 6; s. 719 - 730
Hlavní autoři:	Sakurai, Y., Mori, Y., Okamoto, H., Nishimura, A., Komura, E., Araki, T., Shiramoto, M.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England 01.09.2015
Témata:	Adult Cross-Over Studies Esomeprazole - administration & dosage Esomeprazole - adverse effects Esomeprazole - therapeutic use Gastric Acid Humans Hydrogen-Ion Concentration Male Middle Aged Proton Pump Inhibitors - therapeutic use Pyrroles - administration & dosage Pyrroles - adverse effects Pyrroles - therapeutic use Rabeprazole - administration & dosage Rabeprazole - adverse effects Rabeprazole - therapeutic use Research Design Sulfonamides - administration & dosage Sulfonamides - adverse effects Sulfonamides - therapeutic use
ISSN:	0269-2813, 1365-2036, 1365-2036
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!